Biotech startup Insamo launches with $12M seed to develop peptide drugs

A new biotech startup launched Wednesday to advance a “Goldilocks” therapeutic modality that could turn some of the industry’s most lucrative drugs into pills.

Berkeley, California-headquartered Insamo was founded in 2022 by a trio of Ph.D. scientists, who have raised a $12 million seed round that…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks